CN110538275A - plant bacteriostatic liquid for field survival and preparation process thereof - Google Patents
plant bacteriostatic liquid for field survival and preparation process thereof Download PDFInfo
- Publication number
- CN110538275A CN110538275A CN201910952755.4A CN201910952755A CN110538275A CN 110538275 A CN110538275 A CN 110538275A CN 201910952755 A CN201910952755 A CN 201910952755A CN 110538275 A CN110538275 A CN 110538275A
- Authority
- CN
- China
- Prior art keywords
- parts
- plant bacteriostatic
- field survival
- solution
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
The invention provides a plant bacteriostatic solution for field survival and a manufacturing process thereof, wherein the plant bacteriostatic solution for field survival comprises the following components: perfoliote knotweed herb, moschus, liquorice, centella, dendrobium, sophora flower, salvia miltiorrhiza, cinnamon, menthol, thymol and the balance of purified water. The plant bacteriostatic solution for field survival has pure plant components, no toxic or side effect and broad-spectrum healing effect on epithelial tissue wounds, and comprises the following components: oral ulcer, wound, skin ulcer, insect bite dermatitis, burn and scald, chemical contact dermatitis, urticaria and the like, and has better application prospect.
Description
Technical Field
the invention relates to gargle care solution, in particular to plant bacteriostatic solution for field survival of pure plants and a preparation process thereof.
Background
the common oral diseases comprise oral ulcer, periodontal disease, dental caries, oral candidiasis, halitosis and the like, and the oral diseases are caused because the oral cavity is not cleaned completely, food residues are remained in the oral cavity to provide a free 'culture medium' for pathogenic bacteria, and the incidence rate of the oral diseases is improved.
In daily life, people are used to select toothpaste for oral cleaning in the morning and at night respectively, the toothpaste is inconvenient to use in ordinary working environments, but the plant bacteriostatic solution for field survival can make up for the defects that the toothpaste is inconvenient to carry and cannot be used anytime and anywhere. The plant bacteriostatic solution for field survival, which is added with the medicinal components, can clean and care the oral cavity at any time and any place, freshen the oral cavity, prevent and treat oral diseases, protect the oral cavity and bring convenience to the work and life of people.
The gargle care solution is a product for cleaning oral cavity and refreshing breath, and is popular with consumers due to convenient carrying and simple use. However, most of the existing gargle care solutions contain preservatives and other additives, and are not suitable for long-term use. Therefore, it is necessary to provide a further solution to the above problems.
Disclosure of Invention
The invention aims to provide a plant bacteriostatic liquid for field survival and a preparation process thereof, which are used for overcoming the defects in the prior art.
In order to realize the aim, the invention provides plant bacteriostatic liquid for field survival, which comprises the following components: perfoliote knotweed herb, moschus, liquorice, centella, dendrobium, sophora flower, salvia miltiorrhiza, cinnamon, menthol, thymol and the balance of purified water.
As an improvement of the plant bacteriostatic solution for field survival, the initial component content of each component for manufacturing the plant bacteriostatic solution for field survival is as follows by mass: 0.5-1.5 parts of perfoliote knotweed herb, 2-5 parts of moschus, 3.5-6.5 parts of liquorice, 4.5-5.5 parts of centella, 1.5-3.5 parts of dendrobium, 4.5-5.5 parts of sophora flower, 1.2-4 parts of salvia miltiorrhiza, 5-6 parts of cinnamomum subavenium, 0.5-2.5 parts of menthol, 0.02-0.04 part of thymol and the balance of purified water.
In order to realize the purpose, the invention provides a manufacturing process of plant bacteriostatic solution for field survival, which comprises the following steps:
S1, providing herba Polygoni Cymosi, moschus, radix Glycyrrhizae, herba Centellae, herba Dendrobii, flos Sophorae, radix Salviae Miltiorrhizae, cortex Cinnamomi, Mentholum, and thymol in the plant antibacterial liquid for field survival;
S2, breaking the wall of each provided component, crushing, and sieving to obtain powder with required particle size;
S3, curing the obtained powder of each component at the temperature of 145-160 ℃;
S4, placing the cured powder of each component in a leaching kettle, adding purified water, and boiling for 1.5-2.0h under the condition of continuous stirring;
S5, filtering the boiled liquid medicine, separating the precipitate, and concentrating the filtrate;
S6, boiling the precipitate for the second time, extracting the concentrated solution, and mixing the concentrated solution with the concentrated solution in the step S5 to obtain the plant bacteriostatic solution for field survival.
As an improvement of the manufacturing process of the invention, a superfine powder cell wall breaking machine with the model of sjy5-8 is used for wall breaking.
As an improvement of the manufacturing process of the present invention, in the sieving, the sieve used in the filtering in the steps S2 and S3 is 250-350 mesh.
As an improvement of the manufacturing process of the invention, the powders of the cured components are stirred and mixed in a leaching kettle under the conditions of 4-5MPa and 150-200 rpm.
as an improvement of the manufacturing process of the present invention, the manufacturing process further includes a step of sterilizing the mixed concentrated solution obtained in step S6 at high temperature.
As an improvement of the manufacturing process of the invention, the temperature of the high-temperature sterilization is 120-125 ℃.
compared with the prior art, the invention has the beneficial effects that: the plant bacteriostatic solution for field survival has pure plant components, no toxic or side effect and broad-spectrum healing effect on epithelial tissue wounds, and comprises the following components: oral ulcer, wound, skin ulcer, insect bite dermatitis, burn and scald, chemical contact dermatitis, urticaria and the like, and has better application prospect.
Detailed Description
the present invention is described in detail below with reference to various embodiments, but it should be noted that these embodiments do not limit the present invention, and those skilled in the art should be able to make functional, methodological, or structural equivalents or substitutions according to these embodiments within the scope of the present invention.
The invention provides a plant bacteriostatic solution for field survival, which comprises the following components: perfoliote knotweed herb, moschus, liquorice, centella, dendrobium, sophora flower, salvia miltiorrhiza, cinnamon, menthol, thymol and the balance of purified water. Preferably, the plant bacteriostatic solution for field survival comprises the following components in parts by mass: 0.5-1.5 parts of perfoliote knotweed herb, 2-5 parts of moschus, 3.5-6.5 parts of liquorice, 4.5-5.5 parts of centella, 1.5-3.5 parts of dendrobium, 4.5-5.5 parts of sophora flower, 1.2-4 parts of salvia miltiorrhiza, 5-6 parts of cinnamomum subavenium, 0.5-2.5 parts of menthol, 0.02-0.04 part of thymol and the balance of purified water.
The technical scheme of the plant bacteriostatic solution for field survival is illustrated by combining with a specific manufacturing process example.
Example 1
Weighing the components in the plant bacteriostatic solution for field survival according to the weight ratio: 0.5 part of perfoliote knotweed herb, 2 parts of moschus, 3.5 parts of liquorice, 4.5 parts of centella, 1.5 parts of dendrobium, 4.5 parts of sophora flower, 1.2 parts of salvia miltiorrhiza, 5 parts of cinnamon, 0.5 part of menthol, 0.02 part of thymol and the balance of purified water.
Respectively breaking cell wall of each weighed component with sjy5-8 superfine powder cell wall breaking machine, pulverizing, and sieving to obtain powder with required particle size.
The obtained powders of the respective components were subjected to aging treatment at 145 ℃.
Placing the cured powder of each component in a leaching kettle, adding purified water, and boiling for 1.5h under the conditions of 4MPa and 150rpm and continuous stirring.
Filtering the boiled liquid medicine, separating the precipitate, and concentrating the filtrate.
And boiling the precipitate for the second time, extracting a concentrated solution of the precipitate, and mixing the concentrated solution with the concentrated solution to obtain the plant bacteriostatic solution for field survival.
example 2
weighing the components in the plant bacteriostatic solution for field survival according to the weight ratio: 1.5 parts of perfoliote knotweed herb, 5 parts of moschus, 6.5 parts of liquorice, 5.5 parts of centella, 3.5 parts of dendrobium, 5.5 parts of sophora flower, 4 parts of salvia miltiorrhiza, 6 parts of cinnamon, 2.5 parts of menthol, 0.04 part of thymol and the balance of purified water.
respectively breaking cell wall of each weighed component with sjy5-8 superfine powder cell wall breaking machine, pulverizing, and sieving to obtain powder with required particle size.
The obtained powders of the components are aged at 160 ℃.
Placing the cured powder of each component in a leaching kettle, adding purified water, and boiling for 2.0h under the conditions of 5MPa and 200rpm and continuous stirring.
filtering the boiled liquid medicine, separating the precipitate, and concentrating the filtrate.
Boiling the precipitate for the second time, and extracting the concentrated solution and mixing with the above concentrated solution. Then, the mixed concentrated solution obtained above was sterilized at a high temperature of 120 ℃.
Toxicity test
The toxicity of the plant bacteriostatic solution for field survival is verified by the following toxicological tests:
The medicinal patches soaked with the plant bacteriostatic solution for field survival are respectively placed on the right buccal mucosa of the adult guinea pig according to the same dosage for 2 hours and 3 times a day. After the final sequential administration, 1 guinea pig was selected for 2h, 12h, and 24h, respectively, and the right buccal mucosa was used as a control, and pathological sections were prepared and observed under an optical microscope. No obvious change in properties was observed. Therefore, the plant bacteriostatic solution for field survival has no toxic or side effect.
In conclusion, the plant bacteriostatic solution for field survival disclosed by the invention has pure plant components, has no toxic or side effect, has a broad-spectrum healing effect on epithelial tissue wounds, and comprises the following components: oral ulcer, wound, skin ulcer, insect bite dermatitis, burn and scald, chemical contact dermatitis, urticaria and the like, and has better application prospect.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (8)
1. The plant bacteriostatic solution for the field survival is characterized by comprising the following components: perfoliote knotweed herb, moschus, liquorice, centella, dendrobium, sophora flower, salvia miltiorrhiza, cinnamon, menthol, thymol and the balance of purified water.
2. the plant bacteriostatic solution for field survival according to claim 1, wherein the initial component contents of the components for manufacturing the plant bacteriostatic solution for field survival are as follows by mass: 0.5-1.5 parts of perfoliote knotweed herb, 2-5 parts of moschus, 3.5-6.5 parts of liquorice, 4.5-5.5 parts of centella, 1.5-3.5 parts of dendrobium, 4.5-5.5 parts of sophora flower, 1.2-4 parts of salvia miltiorrhiza, 5-6 parts of cinnamomum subavenium, 0.5-2.5 parts of menthol, 0.02-0.04 part of thymol and the balance of purified water.
3. A manufacturing process of plant bacteriostatic solution for field survival is characterized by comprising the following steps:
S1, providing herba Polygoni Cymosi, moschus, radix Glycyrrhizae, herba Centellae, herba Dendrobii, flos Sophorae, radix Salviae Miltiorrhizae, cortex Cinnamomi, Mentholum, and thymol in the plant antibacterial liquid for field survival;
S2, breaking the wall of each provided component, crushing, and sieving to obtain powder with required particle size;
S3, curing the obtained powder of each component at the temperature of 145-160 ℃;
S4, placing the cured powder of each component in a leaching kettle, adding purified water, and boiling for 1.5-2.0h under the condition of continuous stirring;
S5, filtering the boiled liquid medicine, separating the precipitate, and concentrating the filtrate;
S6, boiling the precipitate for the second time, extracting the concentrated solution, and mixing the concentrated solution with the concentrated solution in the step S5 to obtain the plant bacteriostatic solution for field survival.
4. The manufacturing process of plant bacteriostatic solution for field survival according to claim 3, wherein an ultrafine powder cell wall breaking machine with the model of sjy5-8 is used for wall breaking.
5. the process for preparing plant bacteriostatic agent for field survival according to claim 3, wherein the screen used in the filtration in steps S2 and S3 is 250-350 mesh.
6. The process for preparing plant bacteriostatic agent for field use according to claim 3, wherein the aged powders of the components are stirred and mixed in the leaching kettle under the conditions of 4-5MPa and 150-200 rpm.
7. the process for preparing plant bacteriostatic agent for field use according to claim 3, wherein said process further comprises the step of sterilizing the mixed concentrated solution obtained in step S6 at high temperature.
8. The process of claim 7, wherein the temperature for high temperature sterilization is 120-125 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910952755.4A CN110538275A (en) | 2019-10-09 | 2019-10-09 | plant bacteriostatic liquid for field survival and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910952755.4A CN110538275A (en) | 2019-10-09 | 2019-10-09 | plant bacteriostatic liquid for field survival and preparation process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110538275A true CN110538275A (en) | 2019-12-06 |
Family
ID=68715301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910952755.4A Pending CN110538275A (en) | 2019-10-09 | 2019-10-09 | plant bacteriostatic liquid for field survival and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110538275A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111700934A (en) * | 2020-08-04 | 2020-09-25 | 苏州知时生物科技有限公司 | Plant-based gel for neurodermatitis and preparation process thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785161A (en) * | 2018-07-02 | 2018-11-13 | 亿利耐雀生物科技有限公司 | A kind of antibacterial mouthwash and preparation method thereof containing licoflavone |
| CN108904707A (en) * | 2018-08-21 | 2018-11-30 | 广州福瑞达医药科技有限公司 | A kind of antibacterial type eyedrops and its configuration method |
-
2019
- 2019-10-09 CN CN201910952755.4A patent/CN110538275A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785161A (en) * | 2018-07-02 | 2018-11-13 | 亿利耐雀生物科技有限公司 | A kind of antibacterial mouthwash and preparation method thereof containing licoflavone |
| CN108904707A (en) * | 2018-08-21 | 2018-11-30 | 广州福瑞达医药科技有限公司 | A kind of antibacterial type eyedrops and its configuration method |
Non-Patent Citations (1)
| Title |
|---|
| 安徽省卫生厅编: "《安徽药材 第5集》", 31 May 1960, 安徽人民出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111700934A (en) * | 2020-08-04 | 2020-09-25 | 苏州知时生物科技有限公司 | Plant-based gel for neurodermatitis and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105770191B (en) | With the composition and its preparation method and application for reducing Periodontal Pathogens active function | |
| CN102138887B (en) | Multifunctional compound rhizoma coptidis Chinese medicinal herb toothpaste | |
| CN104107161B (en) | A kind of collutory nursing oral cavity and preparation method thereof | |
| CN101157884A (en) | Soap containing vegetable essential oil | |
| CN104688629A (en) | Mouthwash for preventing oral ulcer inflammation | |
| CN102451111A (en) | Natural bacteriostasis hand cleanser and its preparation method | |
| CN110538275A (en) | plant bacteriostatic liquid for field survival and preparation process thereof | |
| CN111281836A (en) | Multi-aspect tooth-protecting dentifrice prepared from pure Chinese herbal medicines and preparation method thereof | |
| CN104873433A (en) | Moxa skin cream and preparing method thereof | |
| CN112107517A (en) | Children's mouth wash containing cymene bacteriostatic agent and preparation method thereof | |
| CN103599182A (en) | Traditional Chinese medicine composition and preparation method thereof, and oral cavity cleaning and nursing product and preparation method thereof | |
| KR101108712B1 (en) | A process for preparing a bathing composition made from a fermented herbal medicine, a bathing composition prepared by the process, and a method of using the bathing composition | |
| CN102908287A (en) | Chinese and western medicine composite preparation toothpaste with propolis and preparation method thereof | |
| KR20030095924A (en) | Process for preparing powder composition for ocher massage using ocher powder and elm bark powder (herbal medicine powder.herb powder) | |
| CN112915057A (en) | Compound coptis chinensis Chinese herbal medicine toothpaste and preparation method thereof | |
| CN112137938A (en) | Gynostemma pentaphylla traditional Chinese medicine toothpaste | |
| CN112057389A (en) | Mite-removing tea bran shower gel and preparation method thereof | |
| CN108272702A (en) | A kind of pre- anti-caries mouthwash | |
| CN109730955A (en) | Toothpaste containing lacquer tree leaf extract | |
| CN102805717B (en) | Preparation method of beautyberry herbal toothpaste | |
| CN103446008B (en) | Magnesium carbonate type toothpaste | |
| CN103445978B (en) | Calcium hydrogen phosphate type toothpaste | |
| CN103417396B (en) | Calcite-type toothpaste | |
| CN112641873A (en) | A collutory containing folium Perillae for preventing dental caries | |
| CN109745263B (en) | Compound traditional Chinese medicine toothpaste containing subprostrate sophora and pseudo-ginseng and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191206 |